SaverOne 2014 (SVRE) VP reports detailed stock option grants and vesting

Rhea-AI Filing Summary

SaverOne 2014 Ltd. executive Meidan Aviram, VP Research & Development, reported existing holdings of employee stock options linked to the company’s Ordinary Shares. These are disclosures of current positions rather than new market transactions.

The holdings include options over 100,000 shares at an exercise price of approximately $0.57 per share expiring on July 7, 2032, 50,000 shares at $2.16 expiring on May 14, 2030, and 90,172 shares at $2.73 expiring on December 17, 2028. Footnotes state the options are vested as of the report date and that 93,750 of the $0.57 options are vested, with the remaining 6,250 scheduled to vest on July 7, 2026.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Meidan Aviram

Role VP Research & Development

Type	Security	Shares	Price	Value
holding	Employee Stock option (right to buy)	--	--	--
holding	Employee Stock option (right to buy)	--	--	--
holding	Employee Stock option (right to buy)	--	--	--

Holdings After Transaction: Employee Stock option (right to buy) — 90,172 shares (Direct, null)

Footnotes (1)

1. The options are vested as of the date of this report. The options were granted on July 7, 2022 and are exercisable at a per share price of 1.639 NIS (approximately $0.57 as of the date of this report), of which options for 93,750 shares are vested and the remaining 6,250 shares are to vest on July 7,2026

Key Figures

Options at ~$0.57: 100,000 shares Options at $2.16: 50,000 shares Options at $2.73: 90,172 shares +2 more

5 metrics

Options at ~$0.57 100,000 shares Exercise price approximately $0.57; expiration July 7, 2032

Options at $2.16 50,000 shares Exercise price $2.16; expiration May 14, 2030

Options at $2.73 90,172 shares Exercise price $2.73; expiration December 17, 2028

Vested $0.57 options 93,750 options Vested as of report date per footnote

Unvested $0.57 options 6,250 options Scheduled to vest on July 7, 2026

Key Terms

Employee Stock option (right to buy), Ordinary Shares, exercise price, vested

4 terms

Employee Stock option (right to buy) financial

"security_title: Employee Stock option (right to buy)"

Ordinary Shares financial

"underlying_security_title: Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

exercise price financial

"are exercisable at a per share price of 1.639 NIS"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vested financial

"The options are vested as of the date of this report."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Meidan Aviram

(Last) (First) (Middle)

C/O SAVERONE 2014 LTD.

EM HAMOSHAVOT RD. 94

(Street)

PETAH TIKVAH 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SaverOne 2014 Ltd. [ SVRE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Research & Development

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock option (right to buy)	12/17/2018	12/17/2028	Ordinary Shares	90,172(1)	$2.73	D
Employee Stock option (right to buy)	05/14/2020	05/14/2030	Ordinary Shares	50,000(1)	$2.16	D
Employee Stock option (right to buy)	07/07/2022	07/07/2032	Ordinary Shares	100,000(2)	$0.57	D

Explanation of Responses:

1. The options are vested as of the date of this report.

2. The options were granted on July 7, 2022 and are exercisable at a per share price of 1.639 NIS (approximately $0.57 as of the date of this report), of which options for 93,750 shares are vested and the remaining 6,250 shares are to vest on July 7,2026

	/s/ Aviram Meidan	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What did SaverOne 2014 (SVRE) executive Meidan Aviram report on Form 3?

Meidan Aviram, VP Research & Development at SaverOne 2014 Ltd., reported his existing holdings of employee stock options on Ordinary Shares. The Form 3 lists these derivative positions, their exercise prices, share amounts, vesting details, and expiration dates, without showing any new buy or sell transactions.

How many SaverOne 2014 (SVRE) shares are covered by Meidan Aviram’s stock options?

Meidan Aviram holds employee stock options over 240,172 Ordinary Shares in total. This includes 100,000 shares at approximately $0.57, 50,000 shares at $2.16, and 90,172 shares at $2.73, each with specified expiration dates and vesting schedules described in the disclosure.

What are the exercise prices and expirations of Meidan Aviram’s SaverOne (SVRE) options?

His options cover 100,000 shares at about $0.57 per share expiring July 7, 2032, 50,000 shares at $2.16 expiring May 14, 2030, and 90,172 shares at $2.73 expiring December 17, 2028. All are employee stock options on Ordinary Shares.

What vesting terms apply to Meidan Aviram’s $0.57 SaverOne (SVRE) stock options?

Footnotes state the options are vested as of the report date and clarify that of the 100,000 options at about $0.57, 93,750 are vested and the remaining 6,250 are scheduled to vest on July 7, 2026, subject to the existing grant terms.

Does Meidan Aviram’s SaverOne (SVRE) Form 3 show any stock purchases or sales?

The disclosure reflects holding entries only for employee stock options and shows no explicit buy or sell transactions. Transaction fields indicate unknown direction with no purchase or sale codes, emphasizing it is an initial report of derivative positions rather than new market activity.